Abstract. The aim of this study was to determine the relationship between serum magnesium (Mg) concentrations in middle-aged and older men, and the occurrence of selected metabolic and hormonal disorders. The study involved a total of 313 men aged 50-75 years, and who underwent standard anthropometric measurements. Also determined were blood serum Mg, lipid parameterstotal cholesterol (TCh), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride (TG) and carbohydrate metabolism parameters -glucose, insulin (I). In men with a normal total testosterone (TT) concentration, serum Mg was significantly higher compared to patients with a total testosterone deficiency. The subjects with metabolic syndrome had lower serum Mg compared to patients without metabolic syndrome. Serum Mg concentration in type 2 diabetes mellitus was lower compared to men without diabetes. In patients with arterial hypertension, serum Mg concentration was lower than in patients without hypertension. Statistically significant negative correlations were found for the relationships between Mg concentration and body mass index, waist-to-hip ratio, abdominal circumference, arterial blood pressure. Statistically significant, positive correlations were found for the relationships between Mg concentration and TT, TCh, LDL concentrations. The lower serum Mg level may be conducive to the development of total testosterone deficiency, arterial hypertension, diabetes, and therefore metabolic syndrome. 
Magnesium (Mg) is the second most abundant intracellular cation in the human body and is necessary as a cofactor in more than 300 enzymatic reactions. Mg is involved in the metabolism of proteins, carbohydrates and lipids, in stabilizing nucleic acids, and influencing the permeability of cell membranes, ion fluxes, and neuromuscular conductivity. In the human body, about 60% of Mg is present in bone, about 20% in skeletal muscle, 19% in other soft tissues, and less than 1% in the extracellular fluid [1] [2] [3] .
Anabolic hormones, including testosterone, dehydroepiandrosterone, estradiol (E 2 ) and insulin-like growth factor (IGF-1) play a significant role in ensuring optimum energy metabolism. Their levels decrease with age, which adversely affects the body's energy system [4] . It is well known that reduced levels of total testosterone (TT) in middle-aged or older men may contribute to abdominal obesity, increased insulin resistance, and type 2 diabetes and metabolic syndrome [5] [6] [7] . For example, in elderly men from Tuscany, decreased concentrations of anabolic hormones were found to be related to higher mortality in that population [8] .
According to the Massachusetts Male Aging Study (MMAS), from 30 years of age, total testosterone decreases by 0.8-1% a year [9] , while according to the multi-center European Male Aging Study (EMAS) total testosterone decreases by 0.4% and free testosterone (FT) by 1.3% a year [10] . According to the multi-center EMAS, lateonset hypogonadism (LOH) occurs in 2.1% men between 40 and 79 years of age, and its incidence increases with age. After adopting more elastic criteria, the incidence of LOH increases in this age group to 5.6-12% [11] . Mortality from all causes is highest in men with low testosterone impacting on their metabolic state, leading to diabetes mellitus, cardiovascular disease, osteoporosis, and sexual dysfunction [12] .
An insufficient supply of macro-and micronutrients, including Mg, may contribute to a loss of muscle mass and reduced exercise capacity [13] . Moreover, anabolic hormones (especially testosterone and IGF-1) and minerals (especially magnesium, zinc and selenium) act synergistically, and their correct concentrations in aging men may have a beneficial effect on the quality of life during this period of life [4] . Low Mg levels may destabilize DNA, decrease protein synthesis and lead to mitochondrial dysfunction [14, 15] . Mg deficiency and aging of the organism itself are associated with oxidative stress, production of free radicals and inflammation [15] .
It is believed that the demand for Mg does not change with age, but diets consisting of processed foods and a limited amount of vegetables usually do not meet the daily requirement for this mineral [16, 17] . In addition to the insufficient supply of Mg in the diet, low concentrations of this mineral can be caused by malabsorption, abnormal redistribution in the body, or excessive loss of Mg via the kidneys or gastrointestinal tract, as well as by some medications [2] .
Many authors show the relationship between Mg intake or status, and the prevalence of chronic diseases: hypertension, lipid disorders, and the presence of cardiovascular disease and metabolic syndrome [2, [18] [19] [20] . Low Mg levels have long been known to be related to type 2 diabetes mellitus and its complications [21] . It is believed that low Mg levels are conducive to the development of insulin resistance [22, 23] . The role of low Mg levels in the development of diabetic complications has been convincingly presented by Corsonello et al. [24] and Xu et al. [25] , who suggested that serum concentrations of Mg correlate inversely with microalbuminuria.
Magnesium, as an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA), has a beneficial effect on lipid metabolism by reducing the synthesis of cholesterol, as well as taking part in the activation of lecithin-cholesterol acetyl transferase (LCAT), which lowers the concentration of low density cholesterol (LDL) and very low density lipoprotein (VLDL) [26] . Mg contributes to an increase in lipoprotein lipase (LPL) activity in muscle tissue, which contributes to the lowering of the concentration of triglyceride (TG) and an increase in the concentration of high-density lipoprotein cholesterol (HDL) [27] . With regard to blood pressure, Mg acts as a blocker of the angiotensin-aldosterone system and enhances the relaxation of vascular smooth muscle, thus lowering blood pressure [27, 28] .
The results of studies on the role of Mg supplementation in the prevention of metabolic and hormonal disorders are inconclusive. Kim et al. [29] suggest that Mg intake may be associated with improved lipid parameters and arterial blood pressure in healthy subjects. Navarette-Cortes et al. [30] demonstrated that in patients with normal Mg levels, mineral supplementation results in no improvement in metabolic parameters. By contrast, Rodriguez-Moran et al. [31] [32] , who argued that Mg supplementation should be recommended as an adjunct therapy in diabetes.
The aim of this study was to determine the relationship between serum Mg levels in men aged 50-75 years of age, and the prevalence of metabolic disorders, including metabolic syndrome and its components (abdominal obesity, lipid and carbohydrate disorders, and hypertension), and hormonal abnormalities, such as a deficiency of total testosterone and free testosterone. Another aim of this research was to establish which factors -hormonal or metabolic -are related to changes in Mg concentration.
Methods and materials
The study involved 313 men, aged 50-75 years (61.3 years ± 6.3). The subjects were recruited from primary health care centers in the city of Szczecin in north-western Poland, where leaflets were distributed with an invitation to participate in a research project. Participation in the study was voluntary. The group did not include men treated with testosterone, dehydroepiandrosterone, steroids, or neuroleptics, those with hypothyroidism or hyperthyroidism, or patients during cancer treatment. Those taking Mg supplementation over the previous month were also excluded. Among the respondents, 51 (16.3%) patients were active smokers. The research lasted from March 2013 to February 2014. The study was approved by the Bioethics Committee of the Pomeranian Medical University in Szczecin (KB-0012/159/12). The participants were informed about the study. Their consent to participate in the study was confirmed by their signature.
All participants were interviewed in order to collect data regarding any chronic diseases and treatment. During the physical examination, we measured height, weight, abdominal circumference, hip circumference and blood pressure. We also calculated body mass index (BMI) and waisthip ratio (WHR). Obesity (BMI≥30) was diagnosed in 87 men (27.8%), overweight (BMI: 25.0-29.9) in 164 men (52.4%) and normal weight (BMI<25) in 62 men (19.8%).
Serum Mg was determined by inductivelycoupled plasma optical emission spectrometry (ICP OES), using an "Optima 2000 DV" camera (Perkin Elmer, Waltham, MA, USA), following the decomposition and removal of organic matrix from serum in a "Microwave" digestion system (Anton Paar, Graz, Austria). After the addition of HNO 3 and H 2 O 2 , samples of blood or serum were placed in a microwave oven equipped with a system for continuous monitoring of temperature and pressure in each vessel. Digestion was performed according to the "Meat" procedure. Calibration was performed using a CertiPUR ® ICP multi-element standard VIII (Merck, Darmstadt, Germany).
Standard solutions were supplemented with reagents used for the digestion in the concentrations that were found in the digested samples. All measurements of the intensity of the emitted radiation were performed at the longer axial optical path of the spectrometer (along the plasma). In order to verify the accuracy of the analytical method, we used determinations in reference material SeronormTM Trace Elements Serum L-2 (SERO AS, Billinstad, Norway). The reference value for Mg was 0.82 mmol/L, and the mean value measured 0.82
The concentrations of total testosterone, free testosterone, E 2 , dehydroepiandrosterone sulfate (DHEA-S) and sex hormone-binding globulin (SHBG) were determined using ELISA kits (DRG-MedTek, Gliwice, Poland). We also calculated the free androgen index (FAI) according to the formula: FAI = concentration of total testosterone/concentration of SHBGx100. Total testosterone deficiency was diagnosed according to the recommendations resulting from the consensus of the International Society of Andrology (ISA), the International Society for the Study of the Aging Male (ISSAM), European Association of Urology (EAU), the European Academy of Andrology (EAA) and the American Society of Andrology (ASA) [33] . Patients in whom testosterone levels were below 8 nmol/L or between 8-12 nmol/L in the presence of clinical symptoms that had been evaluated in the standardized Androgen Deficiency in the Aging Male (ADAM) questionnaire, qualified for inclusion in the total testosterone-deficient group. Free testosterone below 65 pg/mL (225 pmol/L) was considered as deficient.
In the men surveyed, we determined the concentrations of glucose, TCh, LDL, HDL and TG by spectrophotometric method and reagent kits (BIOLABO, Aqua-Med, Łódź, Poland). Serum insulin was determined by ELISA and reagent kits (DRG Medtek). In non-diabetic patients, the insulin ratio was calculated using the homeostasis model assessment -insulin resistance (HOMA-IR) according to the formula: HOMA-IR = fasting plasma glucose (mmol/L) × fasting insulin levels (U/mL)/22.5. Metabolic syndrome was diagnosed according to the criteria of the International Diabetes Federation (IDF) of 2005. Metabolic syndrome was diagnosed in 161 men (51.4%) [34] . Diabetes was present in 55 patients (17.6%), hypertension in 171 patients (54.6%) and obesity (BMI>30) in 87 patients (27.8%). Statins were being taken by 49 of the men (15.7%).
Statistical analysis was carried out using Statistica PL software (Statsoft, Tulsa, OK, USA). The group characteristics for the traits studied included arithmetic mean and standard deviation, median and range. The distribution of results was examined using a Shapiro-Wilk test. Due to the non-normal distribution of results, intergroup comparisons were performed with the MannWhitney U test (which does not assume that the variables are normally distributed). The correlations between the analyzed variables were calculated with Spearman's rank correlation coefficient (r s ). Logistic regression was used for the calculation of the odds ratios (OR) and 95% confidence intervals (CI). The level of significance was p≤0.05.
Results
Mean anthropometric parameters, lipid and carbohydrate metabolism, and hormone concentrations are presented in table 1 .
Mg concentrations in men with normal serum total testosterone levels were significantly higher compared to the total testosterone -deficient men (p = 0.006) (table 2) but were similar between the men with normal and deficient free testosterone. In the men with metabolic syndrome, Mg levels were significantly lower than those without metabolic syndrome (p = 0.018). Mean Mg level in diabetics was significantly lower than in men without diabetes (p = 0.0001). There was no difference in Mg levels between the obese and non-obese men studied. In patients with hypertension, the Mg level was significantly lower than in men without hypertension (p = 0.00012).
In assessing the correlation between anthropometric parameters and serum Mg concentration in the study group (n = 313), statistically significant negative correlations were found for the following relationships with BMI, WHR, waist circumference, and arterial blood pressure (table 3) . Statistically significant positive correlations were found for the relationships between serum Mg concentration and total testosterone, TCh and LDL.
A logistic regression model showed that lower Mg increased the risk of metabolic syndrome (p = 0.008, OR = 0.86, 95%CI: 0.764-0.961), type 2 diabetes (p<0.0001, OR = 0.67, 95%CI: 0.567-0.797) and hypertension (p = 0.003, OR = 0.84, 95%CI: 0.743-0.942). It also showed no effect of serum Mg concentration on the total testosterone concentration in the study group (p = 0.052, OR = 0.90, 95%CI: 0.805-1.001). In addition, 
Discussion
Despite a large number of publications available concerning Mg compounds and metabolic disorders, the number of such studies on andropausal men is limited. In this study, men with total testosterone deficiency, as well as those with metabolic syndrome, diabetes and hypertension, had serum Mg concentrations significantly lower than men without these conditions. This is in line with the observations of many authors regarding the relationship between serum Mg levels and metabolic syndrome, diabetes and hypertension, suggesting that reduced serum Mg favors the development of these diseases [20, 35] . We found positive correlation between total testosterone and Mg concentrations. It may be connected with the fact that lowered total testosterone levels can be found in men with metabolic disorders (metabolic syndrome, type 2 diabetes, abdominal obesity), which are more frequent in Mg deficiency.
Testosterone deficiency associated with aging often coexists with metabolic disorders [36] [37] [38] , and low Mg concentrations may to be a factor that contributes to the incidence of testosterone deficiency in aging men. Maggio et al. [39] found that in men over 65 years of age, serum Mg concentrations are strongly and independently associated with anabolic hormones, including total testosterone. However, literature available on the relationship between Mg and hormonal status of men in andropausal age is scarce, and further studies on the effect of Mg on the aging process are necessary before any definite conclusions can be drawn.
In this study, Mg concentration was significantly lower in men with metabolic syndrome than in men without the condition, which is consistent with results found by Guerrero-Romerro et al. [40, 41] . Also male and female Shanghai residents with metabolic syndrome were found to have reduced serum Mg concentrations [42] . In contrast, Mg levels in men who were overweight or obese (BMI>25) were not significantly different from patients of normal weight.
Although the research by Guerro-Romerro et al. [41] showed a negative correlation between magnesemia and obesity, the paper examined only people with simple obesity, but without other metabolic disorders (metabolically healthy, obese (MHO) phenotypes). Other studies report lower Mg concentrations in people with excess body weight [43, 44] . In the present study, we found a statistically significant, negative correlation between serum Mg-BMI and BMI-WHR, indicating a relationship between the factors measured. Similar results were obtained by Song et al. [45] . However, many authors emphasize that the relationship between Mg concentration and obesity is not clear and requires further research. It should be noted that obese people often have disorders of carbohydrate and lipid metabolism, as well as high blood pressure, which suggests the potential role of low levels of Mg [46] .
Our results confirm reports on lower Mg levels in diabetics [24, 40, 47, 48] . A statistically significant, negative correlation between serum Mg and glucose in non-diabetics confirmed that lower concentrations of Mg promoted higher concentrations of glucose.
In the present study, we observed statistically significant, positive correlations between Mg and TCh and between Mg and LDL. Neither of these lipid parameters is included in the diagnostic criteria for metabolic syndrome, and therefore these results do not pertain to the relationship between Mg and the disorder, but suggest that higher Mg levels may contribute to increased TCh and LDL. Similarly, Randell et al. [49] found positive correlations between Mg and TCh and between Mg and LDL. In contrast, the results of Mahalle et al. [50] indicate that lower Mg levels are associated with higher TCh and LDL, and lower HDL. These authors believe that Mg supplementation may have a beneficial effect on the prevention of cardiovascular diseases. Guerrero-Romero [35] suggests that hypomagnesemia contributes to lower HDL. Despite all of these reports, in the present study we found no statistically significant correlation between serum concentrations of Mg and HDL.
In a study on patients with metabolic syndrome, Mg supplementation (three months, 400 mg/day) had no effect on improving lipid and carbohydrate metabolism [51] . However, in patients with type 2 diabetes, three months of oral Mg supple-mentation resulted in significantly reduced LDL and fasting glucose compared to the control group receiving placebo [32] . Given the differing results of these studies, it seems that it is necessary to undertake research on the role of Mg and Mg supplementation in the prevention of metabolic disorders.
In the present study, men with hypertension had lower Mg levels than men without hypertension. There was also a statistically significant negative correlation between Mg and systolic blood pressure. Studies published in the 1990s showed a lower concentration of intracellular Mg in patients with primary hypertension [52, 53] . However, studies evaluating the effect of Mg supplementation on the reduction of blood pressure are inconclusive. Some of them show a beneficial effect of Mg supplementation [54, 55] while others do not [56] , this may result from variability in the degree of response in treated patients [55] .
Conclusions
In men between 50 and 75 years of age, lower concentrations of Mg are associated with a higher occurrence of metabolic disorders (metabolic syndrome, type 2 diabetes, abdominal obesity), and hypertension. Mg concentration is associated with total testosterone concentrations: however, lower levels of total testosterone can be rather associated with metabolic abnormalities.
